Buying or selling a cannabis business in Hawaii

Is cannabis legal in Hawaii?

For registered patients only. The programme sits with the Department of Health’s Office of Medical Cannabis Control and Regulation (OMCCR), under HRS chapter 329D and administrative rules chapter 11-850. Adult-use sales are illegal.

Legalisation has repeatedly passed the Senate and died in the House. In the 2026 session the main legalisation bills stalled again, and the fallback measure, a low-dose bill capping servings at 5 mg THC, cleared the Senate but not the House. Anyone underwriting a Hawaii deal on an adult-use conversion is underwriting a guess.

What licences exist, and how many?

Eight, and no more for now. Rule 11-850-5 sets the allocation: three licences for the City and County of Honolulu, two for Hawaii County, two for Maui County and one for Kauai. The same rule allows additional licences based on qualifying-patient need, capped at one further licence per five hundred qualifying patients in a county, but none has been issued. Every licence is vertically integrated: a licensee grows, manufactures and retails under the one licence, and there is no standalone cultivation, manufacturing or retail licence to buy.

Item	Hawaii rule
Licences statewide	8: Honolulu 3, Hawaii 2, Maui 2, Kauai 1
Last issuance	29 April 2016; no window since
Structure	Vertically integrated; several licensees run three or four retail sites
Application fee	$5,000, non-refundable
Initial licence fee	$75,000
Annual renewal	$50,000
Minimum capital shown	$1,000,000 per licence plus $100,000 per retail location

Fee and capital figures come from HRS 329D-4 and HRS 329D-3. With a closed window and a hard cap, Hawaii is one of the tightest limited-licence states in the country, which is the main thing supporting licence value here.

How does a sale work in Hawaii?

Through department approval, not assignment. Rule 11-850-8 states that a dispensary licence may not be sold or otherwise transferred from one person to another except with the prior written approval of the department, following notice under HRS 329D-5.5. The same rule limits any person to one dispensary licence, which forecloses an in-state roll-up of two or more of the eight.

Three practical consequences:

1. The buyer has to qualify on its own facts. Approval is not a formality; the incoming owners must satisfy the same criminal-history, capital and residency tests as an original applicant. The general mechanics are in change of ownership approval.
2. Changes get reported early. Under rule 11-850-27 a licensee must notify the department in writing at least 14 days before any change that may affect its qualifications, with supporting documentation.
3. Walking away is not a fallback. Surrender under rule 11-850-26 requires destruction of all inventory and returns none of the licence fee.

Residency and ownership limits

This is the binding constraint on Hawaii deals. HRS 329D-3 requires the individual applicant to have been a Hawaii legal resident for at least five years before application, and requires the applying entity to be not less than 51 percent held by Hawaii legal residents, or entities wholly controlled by them, meeting the same five-year test. A mainland buyer cannot take control. Structures that reach the same economics through debt, management fees or profit interests run straight into true-party-of-interest analysis, so they belong in front of Hawaii counsel before an LOI is signed. Hawaii’s rule is stricter than most; see ownership caps and residency rules by state.

Taxes and track-and-trace

There is no cannabis excise or potency tax. Dispensary sales carry the general excise tax of 4 percent, plus the 0.5 percent county surcharge in Honolulu, Hawaii and Kauai counties, for 4.5 percent in those three. The Department of Health’s own tax working group report confirms the absence of a dedicated cannabis tax. Hawaii has not enacted a 280E decoupling statute, which matters less than it used to: because every Hawaii licensee is state-licensed medical, the April 2026 Schedule III order takes qualifying activity outside 280E going forward, and state conformity carries the deductions through. Hawaii uses BioTrack rather than Metrc for seed-to-sale reporting.

Market conditions

Small, stable and unusually well captured. BioTrack recorded about $5.34 million of dispensary sales in March 2025, roughly $64 million annualised, against 28,735 registered patients as of December 2025. An OMCCR-commissioned economic analysis published in December 2025 found the regulated channel takes roughly 86 percent of what registered patients spend, while accounting for about a third of all cannabis consumed in the state, and modelled $59 million to $95 million of monthly sales within five years if adult-use were legalised. Most of the volume is on Oahu; see Honolulu.

What this means for sellers and buyers

Sellers. You hold one of eight licences in a state with a closed window, no roll-up risk from the other seven, and a federal tax position that improved in April 2026. The buyer pool is narrow because control must stay with five-year Hawaii residents, so the realistic counterparty is a local group, an existing investor, or a mainland party taking a minority position. Build the residency and approval path into the process from the start rather than after an LOI.

Buyers. Verify residency-qualified equity before anything else, then diligence BioTrack data against the financials as set out in verifying revenue with track-and-trace data. Price on the medical patient base that exists today, not on an adult-use conversion. Hawaii has not published a licence transfer fee, so confirm current fees with OMCCR. This page is educational, not legal or tax advice.